Market Analysis and Insights:
In 2021, the Global Human Milk Oligosaccharides (HMO) market size was valued at USD 378.52 Million, increased from USD 83.73 Million in 2017, and the market is forecasted to reach USD 1055.83 Million by 2028, growing at CAGR of 14.54% between 2022 and 2028.
The global main manufacturers of Human Milk Oligosaccharides (HMO) include Abbott, Inbiose, Glycom, Chr. Hansen (Jennewein), ZuChem, etc. In 2021, the global top 3 largest players have a share approximately 80.96% in terms of revenue.
Scope and Market Size:
The global Human Milk Oligosaccharides (HMO) market is segmented by region (country), company, by Type, and by Application. Players, stakeholders, and other participants in the global Human Milk Oligosaccharides (HMO) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type, and by Application for the period 2017-2028.
By Company
- Abbott
- Inbiose
- Glycom
- Chr. Hansen (Jennewein)
- Elicityl SA
- ZuChem
Segment by Type
- 2'-FL & 3-FL
- Sialyllactose, LNT & LNnT, etc.
Segment by Application
- Infant Formula
- Functional Food & Beverages
- Food/Medical Supplements, etc.
By Region
- Asia-Pacific
- China
- Japan
- South Korea
- Australia
- Rest of APAC
- Europe
- Germany
- UK
- France
- Belgium
- Denmark
- Rest of Europe
TABLE OF CONTENTS
1 HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET OVERVIEW
- 1.1 HUMAN MILK OLIGOSACCHARIDES (HMO) PRODUCT OVERVIEW
- 1.2 HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET SEGMENT BY TYPE
- 1.2.1 2'-FL & 3-FL
- 1.2.2 SIALYLLACTOSE, LNT & LNNT, ETC.
- 1.3 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET SIZE BY TYPE
- 1.3.1 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET SIZE OVERVIEW BY TYPE (2017-2028)
- 1.3.2 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) HISTORIC MARKET SIZE REVIEW BY TYPE (2017-2022)
- 1.3.3 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) FORECASTED MARKET SIZE BY TYPE (2023-2028)
- 1.4 KEY REGIONS MARKET SIZE SEGMENT BY TYPE
- 1.4.1 NORTH AMERICA HUMAN MILK OLIGOSACCHARIDES (HMO) SALES BREAKDOWN BY TYPE (2017-2022)
- 1.4.2 EUROPE HUMAN MILK OLIGOSACCHARIDES (HMO) SALES BREAKDOWN BY TYPE (2017-2022)
- 1.4.3 ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES (HMO) SALES BREAKDOWN BY TYPE (2017-2022)
2 HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET COMPETITION BY COMPANY
- 2.1 GLOBAL TOP PLAYERS BY HUMAN MILK OLIGOSACCHARIDES (HMO) SALES (2018-2022)
- 2.2 GLOBAL TOP PLAYERS BY HUMAN MILK OLIGOSACCHARIDES (HMO) REVENUE (2018-2022)
- 2.3 GLOBAL TOP PLAYERS BY HUMAN MILK OLIGOSACCHARIDES (HMO) PRICE (2018-2022)
- 2.4 DATE OF KEY MANUFACTURERS ENTER INTO HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET
- 2.5 KEY MANUFACTURERS HUMAN MILK OLIGOSACCHARIDES (HMO) PRODUCT OFFERED
- 2.6 MERGERS & ACQUISITIONS, EXPANSION
3 HUMAN MILK OLIGOSACCHARIDES (HMO) STATUS AND OUTLOOK BY REGION
- 3.1 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET SIZE AND CAGR BY REGION: 2017 VS 2021 VS 2028
- 3.2 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) HISTORIC MARKET SIZE BY REGION
- 3.2.1 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VOLUME BY REGION (2017-2022)
- 3.2.2 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VALUE BY REGION (2017-2022)
- 3.2.3 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) PRICE BY REGION (2017-2022)
- 3.3 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) FORECASTED MARKET SIZE BY REGION
- 3.3.1 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VOLUME BY REGION (2023-2028)
- 3.3.2 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VALUE BY REGION (2023-2028)
- 3.3.3 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) PRICE BY REGION (2023-2028)
4 HUMAN MILK OLIGOSACCHARIDES (HMO) BY APPLICATION
- 4.1 HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET SEGMENT BY APPLICATION
- 4.1.1 INFANT FORMULA
- 4.1.2 FUNCTIONAL FOOD & BEVERAGES
- 4.1.3 FOOD/MEDICAL SUPPLEMENTS AND OTHERS
- 4.2 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET SIZE BY APPLICATION
- 4.2.1 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET SIZE OVERVIEW BY APPLICATION (2017-2028)
- 4.2.2 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) HISTORIC MARKET SIZE REVIEW BY APPLICATION (2017-2022)
- 4.2.3 GLOBAL HUMAN MILK OLIGOSACCHARIDES (HMO) FORECASTED MARKET SIZE BY APPLICATION (2023-2028)
- 4.3 KEY REGIONS MARKET SIZE SEGMENT BY APPLICATION
- 4.3.1 NORTH AMERICA HUMAN MILK OLIGOSACCHARIDES (HMO) SALES BREAKDOWN BY APPLICATION (2017-2022)
- 4.3.2 EUROPE HUMAN MILK OLIGOSACCHARIDES (HMO) SALES BREAKDOWN BY APPLICATION (2017-2022)
- 4.3.3 ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES (HMO) SALES BREAKDOWN BY APPLICATION (2017-2022)
5 NORTH AMERICA HUMAN MILK OLIGOSACCHARIDES (HMO) BY COUNTRY
- 5.1 NORTH AMERICA HUMAN MILK OLIGOSACCHARIDES (HMO) HISTORIC MARKET SIZE BY COUNTRY
- 5.1.1 NORTH AMERICA HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VOLUME BY COUNTRY (2017-2022)
- 5.1.2 NORTH AMERICA HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VALUE BY COUNTRY (2017-2022)
- 5.2 NORTH AMERICA HUMAN MILK OLIGOSACCHARIDES (HMO) FORECASTED MARKET SIZE BY COUNTRY
- 5.2.1 NORTH AMERICA HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VOLUME BY COUNTRY (2023-2028)
- 5.2.2 NORTH AMERICA HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VALUE BY COUNTRY (2023-2028)
6 EUROPE HUMAN MILK OLIGOSACCHARIDES (HMO) BY COUNTRY
- 6.1 EUROPE HUMAN MILK OLIGOSACCHARIDES (HMO) HISTORIC MARKET SIZE BY COUNTRY
- 6.1.1 EUROPE HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VOLUME BY COUNTRY (2017-2022)
- 6.1.2 EUROPE HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VALUE BY COUNTRY (2017-2022)
- 6.2 EUROPE HUMAN MILK OLIGOSACCHARIDES (HMO) FORECASTED MARKET SIZE BY COUNTRY
- 6.2.1 EUROPE HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VOLUME BY COUNTRY (2023-2028)
- 6.2.2 EUROPE HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VALUE BY COUNTRY (2023-2028)
7 ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES (HMO) BY REGION
- 7.1 ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES (HMO) HISTORIC MARKET SIZE BY REGION
- 7.1.1 ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VOLUME BY REGION (2017-2022)
- 7.1.2 ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VALUE BY REGION (2017-2022)
- 7.2 ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES (HMO) FORECASTED MARKET SIZE BY REGION
- 7.2.1 ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VOLUME BY REGION (2023-2028)
- 7.2.2 ASIA-PACIFIC HUMAN MILK OLIGOSACCHARIDES (HMO) SALES IN VALUE BY REGION (2023-2028)
8 COMPANY PROFILES AND KEY FIGURES IN HUMAN MILK OLIGOSACCHARIDES (HMO) BUSINESS
- 8.1 ABBOTT
- 8.1.1 ABBOTT CORPORATION INFORMATION
- 8.1.2 ABBOTT INTRODUCTION AND BUSINESS OVERVIEW
- 8.1.3 ABBOTT HUMAN MILK OLIGOSACCHARIDES (HMO) SALES, REVENUE AND GROSS MARGIN (2018-2022)
- 8.1.4 ABBOTT HUMAN MILK OLIGOSACCHARIDES (HMO) PRODUCTS OFFERED
- 8.1.5 ABBOTT RECENT DEVELOPMENT
- 8.2 INBIOSE
- 8.2.1 INBIOSE CORPORATION INFORMATION
- 8.2.2 INBIOSE INTRODUCTION AND BUSINESS OVERVIEW
- 8.2.3 INBIOSE HUMAN MILK OLIGOSACCHARIDES (HMO) SALES, REVENUE AND GROSS MARGIN (2018-2022)
- 8.2.4 INBIOSE HUMAN MILK OLIGOSACCHARIDES (HMO) PRODUCTS OFFERED
- 8.2.5 INBIOSE RECENT DEVELOPMENT
- 8.3 GLYCOM
- 8.3.1 GLYCOM CORPORATION INFORMATION
- 8.3.2 GLYCOM INTRODUCTION AND BUSINESS OVERVIEW
- 8.3.3 GLYCOM HUMAN MILK OLIGOSACCHARIDES (HMO) SALES, REVENUE AND GROSS MARGIN (2018-2022)
- 8.3.4 GLYCOM HUMAN MILK OLIGOSACCHARIDES (HMO) PRODUCTS OFFERED
- 8.3.5 GLYCOM RECENT DEVELOPMENT
- 8.4 CHR. HANSEN (JENNEWEIN)
- 8.4.1 CHR. HANSEN (JENNEWEIN) CORPORATION INFORMATION
- 8.4.2 CHR. HANSEN (JENNEWEIN) INTRODUCTION AND BUSINESS OVERVIEW
- 8.4.3 CHR. HANSEN (JENNEWEIN) HUMAN MILK OLIGOSACCHARIDES (HMO) SALES, REVENUE AND GROSS MARGIN (2018-2022)
- 8.4.4 CHR. HANSEN (JENNEWEIN) HUMAN MILK OLIGOSACCHARIDES (HMO) PRODUCTS OFFERED
- 8.4.5 CHR. HANSEN (JENNEWEIN) RECENT DEVELOPMENT
- 8.5 ELICITYL SA
- 8.5.1 ELICITYL SA CORPORATION INFORMATION
- 8.5.2 ELICITYL SA INTRODUCTION AND BUSINESS OVERVIEW
- 8.5.3 ELICITYL SA HUMAN MILK OLIGOSACCHARIDES (HMO) SALES
- 8.5.4 ELICITYL SA HUMAN MILK OLIGOSACCHARIDES (HMO) PRODUCTS OFFERED
- 8.6 ZUCHEM
- 8.6.1 ZUCHEM CORPORATION INFORMATION
- 8.6.2 ZUCHEM INTRODUCTION AND BUSINESS OVERVIEW
- 8.6.3 ZUCHEM HUMAN MILK OLIGOSACCHARIDES (HMO) SALES
- 8.6.4 ZUCHEM HUMAN MILK OLIGOSACCHARIDES (HMO) PRODUCTS OFFERED
- 8.6.5 ZUCHEM RECENT DEVELOPMENT
9 UPSTREAM, OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
- 9.1 HUMAN MILK OLIGOSACCHARIDES (HMO) KEY RAW MATERIALS
- 9.2 MANUFACTURING COST STRUCTURE
- 9.2.1 RAW MATERIALS
- 9.2.2 LABOR COST
- 9.2.3 MANUFACTURING EXPENSES
- 9.3 HUMAN MILK OLIGOSACCHARIDES (HMO) INDUSTRIAL CHAIN ANALYSIS
- 9.4 HUMAN MILK OLIGOSACCHARIDES (HMO) MARKET DYNAMICS
- 9.4.1 INDUSTRY TRENDS
- 9.4.2 MARKET DRIVERS
- 9.4.3 MARKET CHALLENGES
10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS
- 10.1 SALES CHANNEL
- 10.2 HUMAN MILK OLIGOSACCHARIDES (HMO) DISTRIBUTORS
- 10.3 HUMAN MILK OLIGOSACCHARIDES (HMO) DOWNSTREAM CUSTOMERS
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
- 12.1 RESEARCH METHODOLOGY
- 12.1.1 METHODOLOGY/RESEARCH APPROACH
- 12.1.2 DATA SOURCE
- 12.2 AUTHOR DETAILS
- 12.3 DISCLAIMER